Geneos Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC (NCT07722741) | Geneos Therapeutics | 2026-09-01 |
| GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC (NCT04251117) | Geneos Therapeutics | 2020-03-01 |
Track Geneos Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.